A phase 1 study of PF-06647020, an antibody-drug conjugate targeting PTK7, in patients with advanced solid tumors

Authors
Category Primary study
JournalEuropean Journal of Cancer
Year 2015
This article has no abstract
Epistemonikos ID: b58068a70fddc43a302beaf8e41b062f2032dc3f
First added on: Feb 07, 2025